146 related articles for article (PubMed ID: 24395656)
1. Promoter methylation-mediated downregulation of PRDM5 contributes to the development of lung squamous cell carcinoma.
Tan SX; Hu RC; Tan YL; Liu JJ; Liu WE
Tumour Biol; 2014 May; 35(5):4509-16. PubMed ID: 24395656
[TBL] [Abstract][Full Text] [Related]
2. Methylation of PRDM2, PRDM5 and PRDM16 genes in lung cancer cells.
Tan SX; Hu RC; Liu JJ; Tan YL; Liu WE
Int J Clin Exp Pathol; 2014; 7(5):2305-11. PubMed ID: 24966940
[TBL] [Abstract][Full Text] [Related]
3. Effect of DR4 promoter methylation on the TRAIL-induced apoptosis in lung squamous carcinoma cell.
Wang W; Qi X; Wu M
Oncol Rep; 2015 Oct; 34(4):2115-25. PubMed ID: 26238205
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation and carcinogenesis of PRDM5 in cervical cancer.
Cheng HY; Chen XW; Cheng L; Liu YD; Lou G
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1821-5. PubMed ID: 20213097
[TBL] [Abstract][Full Text] [Related]
5. Promoter methylation of MGMT, MLH1 and RASSF1A tumor suppressor genes in head and neck squamous cell carcinoma: pharmacological genome demethylation reduces proliferation of head and neck squamous carcinoma cells.
Koutsimpelas D; Pongsapich W; Heinrich U; Mann S; Mann WJ; Brieger J
Oncol Rep; 2012 Apr; 27(4):1135-41. PubMed ID: 22246327
[TBL] [Abstract][Full Text] [Related]
6. Methylation-associated silencing of death-associated protein kinase gene in laryngeal squamous cell cancer.
Kong WJ; Zhang S; Guo C; Zhang S; Wang Y; Zhang D
Laryngoscope; 2005 Aug; 115(8):1395-401. PubMed ID: 16094112
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of connexin 26 in human lung cancer is related to promoter methylation.
Chen Y; Hühn D; Knösel T; Pacyna-Gengelbach M; Deutschmann N; Petersen I
Int J Cancer; 2005 Jan; 113(1):14-21. PubMed ID: 15386363
[TBL] [Abstract][Full Text] [Related]
8. XAF1 is frequently methylated in human esophageal cancer.
Chen XY; He QY; Guo MZ
World J Gastroenterol; 2012 Jun; 18(22):2844-9. PubMed ID: 22719195
[TBL] [Abstract][Full Text] [Related]
9. Abnormal hypermethylation and clinicopathological significance of Axin gene in lung cancer.
Yang LH; Xu HT; Li QC; Jiang GY; Zhang XP; Zhao HY; Xu K; Wang EH
Tumour Biol; 2013 Apr; 34(2):749-57. PubMed ID: 23192643
[TBL] [Abstract][Full Text] [Related]
10. KRAB zinc-finger protein 382 regulates epithelial-mesenchymal transition and functions as a tumor suppressor, but is silenced by CpG methylation in gastric cancer.
Pei L; He X; Li S; Sun R; Xiang Q; Ren G; Xiang T
Int J Oncol; 2018 Sep; 53(3):961-972. PubMed ID: 29956735
[TBL] [Abstract][Full Text] [Related]
11. Identification of GPX3 epigenetically silenced by CpG methylation in human esophageal squamous cell carcinoma.
He Y; Wang Y; Li P; Zhu S; Wang J; Zhang S
Dig Dis Sci; 2011 Mar; 56(3):681-8. PubMed ID: 20725785
[TBL] [Abstract][Full Text] [Related]
12. Study on RIZ1 gene promoter methylation status in human esophageal squamous cell carcinoma.
Dong SW; Zhang P; Liu YM; Cui YT; Wang S; Liang SJ; He Z; Sun P; Wang YG
World J Gastroenterol; 2012 Feb; 18(6):576-82. PubMed ID: 22363126
[TBL] [Abstract][Full Text] [Related]
13. Protocadherin 10 is frequently downregulated by promoter methylation and functions as a tumor suppressor gene in non-small cell lung cancer.
Tang X; Yin X; Xiang T; Li H; Li F; Chen L; Ren G
Cancer Biomark; 2012-2013; 12(1):11-9. PubMed ID: 23321465
[TBL] [Abstract][Full Text] [Related]
14. Decreased expression of retinoblastoma protein-interacting zinc-finger gene 1 in human esophageal squamous cell cancer by DNA methylation.
Dong SW; Cui YT; Zhong RR; Liang DC; Liu YM; Wang YG; He Z; Wang S; Liang SJ; Zhang P
Clin Lab; 2012; 58(1-2):41-51. PubMed ID: 22372344
[TBL] [Abstract][Full Text] [Related]
15. Emerging role of PR domain containing 5 (PRDM5) as a broad tumor suppressor in human cancers.
Shu XS
Tumour Biol; 2015 Jan; 36(1):1-3. PubMed ID: 25501702
[No Abstract] [Full Text] [Related]
16. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
[TBL] [Abstract][Full Text] [Related]
17. Methylation and expression of the tumour suppressor, PRDM5, in colorectal cancer and polyp subgroups.
Bond CE; Bettington ML; Pearson SA; McKeone DM; Leggett BA; Whitehall VL
BMC Cancer; 2015 Jan; 15():20. PubMed ID: 25613750
[TBL] [Abstract][Full Text] [Related]
18. The epigenetic modifier PRDM5 functions as a tumor suppressor through modulating WNT/β-catenin signaling and is frequently silenced in multiple tumors.
Shu XS; Geng H; Li L; Ying J; Ma C; Wang Y; Poon FF; Wang X; Ying Y; Yeo W; Srivastava G; Tsao SW; Yu J; Sung JJ; Huang S; Chan AT; Tao Q
PLoS One; 2011; 6(11):e27346. PubMed ID: 22087297
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer.
Chang HC; Cho CY; Hung WC
Cancer Sci; 2007 Feb; 98(2):169-73. PubMed ID: 17233834
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation and downregulation of sall3 in human hepatocellular carcinoma.
Yang XX; Sun JZ; Li FX; Wu YS; Du HY; Zhu W; Li XH; Li M
World J Gastroenterol; 2012 Jun; 18(21):2719-26. PubMed ID: 22690083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
